InsiderInsights’ Daily Round Up articles rate the “Significance” of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the “Significance” of an insider transaction, however, and often not even the most important one.
When a new insider transaction occurs, our programs mathematically score the significance of the company’s 3-month insider profile based on numerous criteria programmed into our expert system.
Stocks that achieve an InsiderInsights Company Rating of “Significant” and “Leaning” Bullish or Bearish have been independently validated to generate alpha as a group and should be considered by investors looking for new long and short investments.
Seasonal Note: Insider filing volumes are waning right on cue, as companies close trading windows to insiders until after March-quarter financials are released. Insider trades pick up again in May, but it will be interesting to see if the immense market sell-off changes executives’ behavior during the normally slower month of April.
———————-
On Today’s Tables:
Insider trades were rated Significant at :
Insider trades were rated Nearly Significant at:
Insider trades were considered Insignificant at:
- Temir (OTCPK:TMRR);
- Steel Partners (SPLP);
- Capital Senior Living (CSU);
- Air Industries (AIRI);
- Tortec Group (OTCPK:TRTK);
- Turning Point Therapeutics (TPTX);
- Nvidia (NVDA);
- Cloudflare (NET);
- Monolithic Power (MPWR);
- Morningstar (MORN);
- Eli Lilly (LLY);
- Emergent Bio (EBS);
- Crowdstrike (OTC:CRWD), and;
- Biohaven Pharmaceutical Holding (BHVN).
There is a Conflicted Insider Signal (both purchases & sales) at:
There is an IPO or Known Corporate Action at:
It’s difficult to argue significance for most transactions made during IPOs, or when insiders make trades during a known corporate action.
Insider Purchases
#: | Filer Name | Insider Titles | Company Name | Ticker | TransType | Dollar Value |
1 |
Viking Global Investors |
BO |
Zentalis Pharm |
ZNTL |
JB* |
$13,050,000 |
2 |
Chan Kong Hoi |
PR,DIR,BO |
Temir |
TMRR |
JB* |
$5,788,896 |
3 |
B Riley Financial |
BO |
Quantum |
QMCO |
B |
$546,584 |
4 |
Frost Phillip Md |
CEO,CB,BO |
Opko Health |
OPK |
B |
$510,984 |
5 |
Dondero James D |
PR,DIR |
Nexpoint Real Estate Finance |
NREF |
B |
$392,301 |
6 |
Taglich Michael N |
DIR,BO |
Air Industries |
AIRI |
JB* |
$74,250 |
7 |
Ribar Brandon |
VP,COO |
Capital Senior Living |
CSU |
B |
$56,158 |
8 |
Smoot Stephen H |
CEO,PR,DIR |
Tortec Group |
TRTK |
JB* |
$50,000 |
9 |
Walker Gordon A |
VP |
Steel Partners |
SPLP |
AB |
$41,876 |
10 |
Shapiro Adam J |
LO,SEC |
SH Em Mkts Inc Fd |
EDI |
B |
$33,550 |
Insider Sales
#: | Filer Name | Insider Titles | Company Name | Ticker | TransType | Dollar Value |
1 |
Warburg Pincus PE X |
DIR |
Crowdstrike |
CRWD |
JS* |
$575,099,972 |
2 |
Stevens Mark A |
DIR |
Nvidia |
NVDA |
S |
$26,431,600 |
3 |
Lilly Endowment |
BO |
Eli Lilly |
LLY |
S |
$24,676,282 |
4 |
Hsing Michael |
CEO,DIR |
Monolithic Power |
MPWR |
AS |
$19,332,570 |
5 |
Foley William P II |
CB,DIR |
Black Knight |
BKI |
S |
$15,495,000 |
6 |
Childs John W |
DIR |
Biohaven Pharmaceutical Holding |
BHVN |
S |
$11,067,969 |
7 |
Zatlyn Michelle |
COO,DIR |
Cloudflare |
NET |
AS |
$4,796,609 |
8 |
Mansueto Joseph D |
CB,DIR,BO |
Morningstar |
MORN |
AS |
$3,377,266 |
9 |
El Hibri Fuad |
CB,DIR,BO |
Emergent Bio |
EBS |
AS |
$2,579,575 |
10 |
Cui Jingrong Jean |
DIR |
Turning Point Therapeutics |
TPTX |
AS |
$2,490,477 |
Source: InsiderInsights.com. Key to Insider Title and Trans Type Codes:B = Open-market Buy; AB = 10b5-1 (automatic) Buy; JB* = Buy indicated as being open-market but not confirmed by trading price range and volume for the session. S = Open-market Sale; AS = 10b5-1 (automatic) Sale; JS* = Sale indicated as being open-market but not confirmed by trading price range and volume for the session.
Did you miss our Previous Daily Round Up?
If you’re serious about using insider data in your investment process, you can’t find a better source of investment ideas (or a better value!) than our Daily Ratings Reports. Subscribe or Trial Now!
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Editor’s Note: This article covers one or more microcap stocks. Please be aware of the risks associated with these stocks.
Be the first to comment